Explore the Fingerprint Trends
Explore the Research Network
This is a list of publications by this organization, listed chronologically starting with the most recent first. The source of publications may be a combination of Scopus and manually entered data from a user. New publications from Scopus appear in this list weekly and publications entered by a user appear instantly. Citation counts start from 1996 and come directly from Scopus.
Alberto S. Pappo; Gilles Vassal; John J. Crowley; Vanessa Bolejack; Pancras C.W. Hogendoorn; Rashmi Chugh; Marc Ladanyi; Joseph F. Grippo; Georgina Dall; Arthur P. Staddon; et al.
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study
Maha Hussain; Stephanie Daignault; Neeraj Agarwal; Petros D. Grivas; Arlene O. Siefker-Radtke; Igor Puzanov; Gary R. MacVicar; Ellis Glenn Levine; Sandy Srinivas; Przemyslaw Twardowski; et al.
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma
Harold J. Burstein; Sarah Temin; Holly Anderson; Thomas A. Buchholz; Nancy E. Davidson; Karen E. Gelmon; Sharon H. Giordano; Clifford A. Hudis; Diana Rowden; Alexander J. Solky; et al.
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update
Alex F. Herrera; Allison Crosby-Thompson; Jonathan W. Friedberg; Gregory A. Abel; Myron S. Czuczman; Leo I. Gordon; Mark S. Kaminski; Michael M. Millenson; Auayporn P. Nademanee; Joyce C. Niland; et al.
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network
Channing J. Paller; Penelope A. Bradbury; S. Percy Ivy; Lesley Seymour; Patricia M. LoRusso; Laurence Baker; Larry Rubinstein; Erich Huang; Deborah Collyar; Susan Groshen; et al.
Design of phase I combination trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee
Kanakadurga Singer; Nicholas Heiniger; Inas Thomas; Francis P. Worden; Ram K. Menon; Ming Chen
Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: Clues to early diagnosis of the paraneoplastic syndromes
Jeremiah W. Bertz; Jianyong Chen; James H. Woods
Effects of pramipexole on the acquisition of responding with opioid-conditioned reinforcement in the rat
Al B. Benson III; Michael I. D'Angelica; Thomas A. Abrams; Chandrakanth Are; P. Mark Bloomston; Daniel T. Chang; Bryan M. Clary; Anne M. Covey; William D. Ensminger; Renuka Iyer; et al.
Hepatobiliary cancers, version 2.2014
Ernest Nadal; Guoan Chen; John R. Prensner; Hiroe Shiratsuchi; Christine Sam; Lili Zhao; Gregory P. Kalemkerian; Dean Brenner; Jules Lin; Rishindra M. Reddy; et al.
KRAS-G12C mutation is associated with poor outcome in surgically resected lung adenocarcinoma
John E. Levine
Less (bacterial diversity) is more (deaths)
Mary K. Askren; Misook Jung; Marc G. Berman; Min Zhang; Barbara Therrien; Scott Peltier; Lynn Ossher; Daniel F. Hayes; Patricia A. Reuter-Lorenz; Bernadine Cimprich
Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation
Kelley M. Kidwell; Steven E. Harte; Daniel F. Hayes; Anna Maria Storniolo; Janet Carpenter; David A. Flockhart; Vered Stearns; Daniel J. Clauw; David A. Williams; Norah Lynn Henry
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy
Paul G. Richardson; Rachid Baz; Michael Wang; Andrzej J. Jakubowiak; Jacob P. Laubach; R. Donald Harvey; Moshe Talpaz; Deborah Berg; Guohui Liu; Jiang Yu; et al.
Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients
Maha Hussain; Paul G. Corn; M. Dror Michaelson; Hans J. Hammers; Joshi J. Alumkal; Charles J. Ryan; Justine Y. Bruce; Susan Moran; Shih-Yuan Lee; H. Mark Lin; et al.
Phase II study of single-agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen
Elizabeth J. Davis; Jennifer L. Beebe-Dimmer; Cecilia L. Yee; Kathleen A. Cooney
Risk of second primary tumors in men diagnosed with prostate cancer: A population-based cohort study
Marie-Eve Charbonneau; Marta J. Gonzalez-Hernandez; Hollis D. Showalter; Nicholas J. Donato; Christiane E. Wobus; Mary X. D. O'Riordan
Small molecule deubiquitinase inhibitors promote macrophage anti-infective capacity
Crystal S. Denlinger; Jennifer A. Ligibel; Madhuri Are; K. Scott Baker; Wendy Demark-Wahnefried; Don Dizon; Debra L. Friedman; Mindy Goldman; Lee Jones; Allison King; et al.
Survivorship: Immunizations and Prevention of Infections, Version 2.2014
Carey Anders; Allison M. Deal; Vandana Abramson; Minetta C. Liu; Anna M. Storniolo; John T. Carpenter; Shannon Puhalla; Rita Nanda; Amal Melhem-Bertrandt; Nancy U. Lin; et al.
TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases
Shubham Pant; Ludmila K. Martin; Susan Geyer; Lai Wei; Katherine Van Loon; Nili Sommovilla; Mark Zalupski; Renuka Iyer; David Fogelman; Andrew H. Ko; et al.
Treatment-related hypertension as a pharmacodynamic biomarker for the efficacy of bevacizumab in advanced pancreas cancer: A pooled analysis of 4 prospective trials of gemcitabine-based therapy with bevacizumab
Patrick J. Hu
Whole genome sequencing and the transformation of C. elegans forward genetics